Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
167.21
-1.27 (-0.75%)
At close: Aug 10, 2026, 4:00 PM EDT
169.00
+1.79 (1.07%)
Pre-market: Aug 11, 2026, 7:54 AM EDT
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Oncology
798.41M737.99M683.60M493.65M309.24M150.56M--
Oncology Growth
158.18%390.17%------
Biopharma and Data
222.66M217.73M210.13M156.13M101.40M45.38M--
Biopharma and Data Growth
119.59%379.84%------
Screening
153.70M115.65M79.73M44.60M20.49M5.68M--
Screening Growth
650.07%1,937.08%------
Licensing and Other
8.34M8.85M8.56M6.38M4.43M1.86M--
Licensing and Other Growth
88.30%375.90%------
Development Services
---17.23M28.10M38.82M51.08M46.72M
Development Services Growth
----63.12%-38.17%-16.77%2.78%-6.43%
Precision Oncology Testing
---184.59M365.19M531.71M687.94M645.54M
Precision Oncology Testing Growth
----71.41%-38.97%-4.56%33.77%32.87%
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Unitied States
1.12B1.01B923.28M851.33M781.99M733.42M697.16M648.18M
Unitied States Growth
42.67%38.30%32.43%31.34%29.51%29.82%32.41%29.19%
International
67.45M65.92M58.74M51.51M47.13M40.84M42.12M44.07M
International Growth
43.13%61.39%39.45%16.88%17.83%5.36%12.56%29.39%